BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8708720)

  • 1. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group.
    Moffat FL; Pinsky CM; Hammershaimb L; Petrelli NJ; Patt YZ; Whaley FS; Goldenberg DM
    J Clin Oncol; 1996 Aug; 14(8):2295-305. PubMed ID: 8708720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab' fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody.
    Moffat FL; Vargas-Cuba RD; Serafini AN; Casillas VJ; Morillo G; Benedetto P; Robinson DS; Ardalan B; Manten HD; Clark KC
    Cancer; 1994 Feb; 73(3 Suppl):836-45. PubMed ID: 8306268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials.
    Patt YZ; Podoloff DA; Curley S; Smith R; Badkhamkar VA; Lamki LM; Jessup MM; Hohn DC
    Cancer; 1993 Jun; 71(12 Suppl):4293-7. PubMed ID: 8389662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of pelvic recurrence of colorectal carcinoma: prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT.
    Stomper PC; D'Souza DJ; Bakshi SP; Rodriguez-Bigas M; Burke PA; Petrelli NJ
    Radiology; 1995 Dec; 197(3):688-92. PubMed ID: 7480740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels.
    Patt YZ; Podoloff DA; Curley S; Kasi L; Smith R; Bhadkamkar V; Charnsangavej C
    J Clin Oncol; 1994 Mar; 12(3):489-95. PubMed ID: 8120546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic antigen immunoscintigraphy complements mammography in the diagnosis of breast carcinoma.
    Goldenberg DM; Abdel-Nabi H; Sullivan CL; Serafini A; Seldin D; Barron B; Lamki L; Line B; Wegener WA
    Cancer; 2000 Jul; 89(1):104-15. PubMed ID: 10897007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of breast cancer imaging with radiolabeled antibodies to carcinoembryonic antigen. Immunomedics Breast Cancer Study Group.
    Goldenberg DM; Wegener W
    Acta Med Austriaca; 1997; 24(2):55-9. PubMed ID: 9227788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioimmunoscintigraphy of colorectal cancer using the anti-CEA monoclonal antibody BW 431/26. Final results].
    Oliva J; Pimentel G; Peralta R; Borrón M; Ortiz R; Gutiérrez J; Guerra J; Quesada W; Dopico R; Casanova F; Baum RP
    Rev Esp Med Nucl; 1999; 18(1):5-15. PubMed ID: 10074212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can postoperative surveillance with serial CEA immunoscintigraphy detect resectable rectal cancer recurrence and potentially improve tumor-free survival?
    Lechner P; Lind P; Goldenberg DM
    J Am Coll Surg; 2000 Nov; 191(5):511-8. PubMed ID: 11085731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer imaging with radiolabeled antibodies: new advances with technetium-99m-labeled monoclonal antibody Fab' fragments, especially CEA-Scan and prospects for therapy.
    Goldenberg DM; Juweid M; Dunn RM; Sharkey RM
    J Nucl Med Technol; 1997 Mar; 25(1):18-23; quiz 34. PubMed ID: 9239599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of CEA antibody scan and computed tomography scan in the follow-up of patients with colorectal cancer].
    García Vicente A; Soriano Castrejón A; González R; Rodado Marina S; Poblete García VM
    Rev Esp Med Nucl; 2002; 21(5):349-55. PubMed ID: 12236910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-carcinoembryonic antigen immunoscintigraphy (technetium-99m-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma.
    Lind P; Lechner P; Arian-Schad K; Klimpfinger M; Cesnik H; Kammerhuber F; Eber O
    J Nucl Med; 1991 Jul; 32(7):1319-25. PubMed ID: 2066784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
    Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
    Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer.
    Hughes K; Pinsky CM; Petrelli NJ; Moffat FL; Patt YZ; Hammershaimb L; Goldenberg DM
    Ann Surg; 1997 Nov; 226(5):621-31. PubMed ID: 9389396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of liver metastases of colorectal cancer with IgG, F(ab')2, and Fab' anti-carcinoembryonic antigen antibodies labeled with 99mTc: the role of metabolism and kinetics.
    Behr T; Becker W; Hannappel E; Goldenberg DM; Wolf F
    Cancer Res; 1995 Dec; 55(23 Suppl):5777s-5785s. PubMed ID: 7493346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies.
    Serafini AN; Klein JL; Wolff BG; Baum R; Chetanneau A; Pecking A; Fischman AJ; Hoover HC; Wynant GE; Subramanian R; Goroff DK; Hanna MG
    J Clin Oncol; 1998 May; 16(5):1777-87. PubMed ID: 9586891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEA-immunoscintigraphy with 99m-technetium correlates with tumour cell differentiation in colorectal cancer.
    Wittig BM; Hach A; Hahn K; Meyer zum Büschenfelde KH; Dippold WG
    Eur J Cancer; 1993; 29A(9):1327-9. PubMed ID: 8343279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of colorectal carcinoma with technetium-99m radiolabeled Fab' fragments.
    Podoloff DA; Patt YZ; Curley SA; Kim EE; Bhadkamkar VA; Smith RE
    Semin Nucl Med; 1993 Apr; 23(2):89-98. PubMed ID: 8511605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
    Delaloye B; Bischof-Delaloye A; Buchegger F; von Fliedner V; Grob JP; Volant JC; Pettavel J; Mach JP
    J Clin Invest; 1986 Jan; 77(1):301-11. PubMed ID: 3484753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiolabeling of an anti-carcinoembryonic antigen antibody Fab' fragment (CEA-Scan) with the positron-emitting radionuclide Tc-94m.
    Griffiths GL; Goldenberg DM; Roesch F; Hansen HJ
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3001s-3003s. PubMed ID: 10541334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.